TIS 0.00% 0.0¢ tissue therapies limited

Ann: VitroGro Sales Planned to Start in June 2012, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 878 Posts.
    lightbulb Created with Sketch. 2
    re: Ann: VitroGro Sales Planned to Start in J... I have to agree with you. IMO sounds like a bit of downramping going on in this thread. My read of the report is that the company has been doing everything to assure that this product gets to the market and the strategy includes getting the best use of what stocks we hold.

    We all knew that June was the forecast date and all the report is to tell us that things are still progressing on schedule.

    The following paragraph was what I found interesting in the report and that alone only inspires my belief in this company and their product.

    “There is strong interest already in VitroGro® from key wound care clinical staff in the UK and Europe and the sales and marketing campaign is ready to proceed immediately following CE Mark approval.”

    IMO it would be wise to hold onto your shares. If I can accumulate more before June at the right price, I will do so. Already have a very nice holding of these shares and nobody will be getting those.

    Good luck to all long term holders.


 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.